Criteria for Assessing Novel Modes of Antidepressant Drug Action in Man

References

• Anderson I. M., Cowen P. J. Chromipramine enhances prolactin and growth hormone responses to L-tryptophan. Psychopharmacology 1986; 8(9)131–133
   Google Scholar
• Batra Biorklund S. A. Binding affinities of four tricyclic antidepressive drugs to muscarinic cholinergic receptors in human parotid gland. Psychopharmacology 1986; 90: 1–4
   PubMed Web of Science ®Google Scholar
• Bearn J. A., Franey C, Arendt J., Checkley S. A. A study of the effect of desipramine treatment alone and in combination with tri-iodorhyromine on 6-sulphatoxymelatonin excretion in depressed patients. British Journal of Psychiatry 1989; 15(5)341–347
   Google Scholar
• Benfield P., Heel R. C., Lewis S. P. Fluoxetine: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in depressive illness. Drugs 1986; 3(2)481–508
   Google Scholar
• Benfield P, Ward A. Fluvoxamine: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in depressive illness. Drugs 1986; 3(2)313–334
   Google Scholar
• Borbely A. A., Trachsel L., Tobler I. Effect of ritanserin on sleep stages and sleep EEG in the rat. European Journal of Pharmacology 1988; 15(6)275–278
   Google Scholar
• Bowsher D. J., Rowe H., Farid N. A., Tenbarge J. B., Lemberger L. Pressor responses to Tyramine and Norepinephrine after subchronic administration of Fluoxetine in man. Life Sciences 1988; 4(2)2569–2575
   Google Scholar
• Cassidy S, Henry J. Fatal toxicity of antidepressant drugs in overdose. British Medical Journal 1987; 29(5)1021–1024
   Google Scholar
• Charig E. M., Anderson I. M., Robinson J. M., Nutt D. J., Cowen P. J. L-Tryptophan and prolactin release: evidence for interaction between 5-HT1and 5-HT1receptors. Human Psychopharmacology 1986; 1: 93–97
   Google Scholar
• Checkley S. A., Thompson C., Burton S., Franey C., Arendt J. Clinical studies of the effect of (+)- and (−) oxaprotiline upon noradrenaline uptake. Psychopharmacology 1985; 8(7)117–118
   Google Scholar
• Checkley S. A., Corn T. H., Glass I. B., Burton S. W., Burke C. A. The responsiveness of central alpha-2 adrenoceptors in depression. The Biology of Depression, J. F. W. Deakin, T. Crow. London, Gaskell 1952; 100–120
   Google Scholar
• Checkley S. A., Corn T. H., Glass I. B., Thompson C., Franey C., Arendt J. Neuroendocrine and other studies of the mechanism of action of desipramine. A Foundation Symposium 1986; 12(3)126–147
   Google Scholar
• Checkley S. A., Park S. B. G. The psychophar-macology of the human pineal. Journal of Psychopharmacology 1986; 1: 20–22
   Google Scholar
• Checkley S. A., Winton F., Franey C., Arendt J. Effects of a phosphodiesterase inhibitor upon the urinary excretion of 6-sulphatoxy melatonin in man. Journal of Psychopharmacology 1987; 1: 20–22
   PubMedGoogle Scholar
• Cohn J. B., Wilcox C. S., Meltzer H. Y. Neuroendocrine effects of Buspirone in patients with generalised anxiety disorder. American Journal of Medicine 1986; 80: 36–40
   PubMed Web of Science ®Google Scholar
• Corn T. H. Reversible inhibitors of monoamine oxidase A: antidepressants without cheese effect?. International Review of Psychiatry 1987; 2: 187–192
   Google Scholar
• Cowen P. J., Green A. R., Grahame-Smith D. G., Braddock L. E. Plasma melatonin during desmethylimipramine treatment: evidence for changes in noradrenergic neurotransmission. British Journal of Pharmacology 1985; 1(9)799–805
   Google Scholar
• Curran H. V., Lader M. H. The psychophar-macological effects of repeated doses of Fluvoxamine, Mianserin and Placebo in healthy human subjects. European Journal of Clinical Pharmacology 1990; 29: 601–607
   Google Scholar
• De Boer, Th. Maura M., Ratters G., de Vos C. J., Wieringa J., Pinder R. M. Neurochemical and autonomic phamacological profiles of the 6-aza-analogue of Mianserin. Org 3770 and its enantiomers. Neuropharmacology 1988; 2(7)399–408
   Google Scholar
• Delini-Stula S., Bischoff A., Mogilnicka E. Rapid changes in functional responsiveness of the 5-HT system after single dose treatment with antidepressants: effects of Maprotiline, Oxaprotiline and its enantiomers. Journal of Psychopharmacology 1986; 3: 7–13
   Google Scholar
• Dillen L, Claeys M., Potter W. Z. Effects of the alpha-2 antagonist Idazoxan on monoaminergic parameters measured in the cerebrospinal fluid of rabbits. European Journal of Pharmacology 1987; 13(7)33–40
   Google Scholar
• Di-Renzo G., Amoroso S., Tagliatela M., Canzoniero L., Basile V., Fatatis A., Annunziato L. Pharmacological characterisation of serotonin receptors involved in the control of prolactin secretion. European Journal of Pharmacology 1989; 16(2)371–373
   Google Scholar
• Doxey J. C., Lane A. C., Roach A. G., Smith C. F.C., Walter D. S. Selective alpha-2 agonists and antagonists. The Pharmacology of Adrenoceptors, E. Szabadi, C. M. Bradshaw, S. R. Nahorski. London, Macmillan 1989; 13–22
   Google Scholar
• Dugovic C., Wauquier A., Leysen J. E., Marrannes R., Janssen P. A. Functional role of 5-HT2receptors in the regulation of sleep and wakefulness in the rat. Psychopharmacology 1989; 9(7)436–442
   Google Scholar
• Elliott H. L., Jones C. R., Reid J. L. Peripheral pre- and post- junctional alpha-2 adrenoceptors in man: studies with RX 781094 a selective alpha-2 antagonist. Journal of Hypertension (Supplement) 1985; 1: 109–111
   Google Scholar
• Risch C. Effect of Fluoxetine on the electrocardiogram. Journal of Clinical Psychiatry 1985; 4(6)42–44
   Google Scholar
• Frhaser A., Brown R., Kocsis J., Caroff S., Amsterdam J., Winokur A., Sweeney J., Stokes P. Patterns of melatonin rhythms in depression. Journal of Neural Transmission (Supplement) 1986; 2(1)269–290
   Google Scholar
• Freedman J. E., Aghajanian G. K. Idazoxan (RX 781094) selectively antagonises alpha-2 adrenoceptors on rat central neurons. European Journal of Pharmacology 1984; 10(5)265–272
   Google Scholar
• Fuller R. W., Perry K. W., Molloy B. B. Effect of an uptake inhibitor on serotonin metabolism in rat brain: studies with Lily 110140. Life Sciences 1974; 1(5)1161–1171
   Google Scholar
• Genco S., Puca F. M., Specchio S., Interno L. M., Castriotta R., Leomanni R., Dammacco F. Metergolina e sonno notturno nell' uomo normale. Bollettino — Societa Italiana Biologia Sperimentale (Napoli) 1977; 5(3)1403–1406
   Google Scholar
• Ghose K, Sedman E. A double blind comparison of the pharmacodynamic effects of single oral doses of Lofepramine, Amitriptyline and Placebo in elderly subjects. European Journal of Clinical Pharmacology 1983; 33: 505–509
   Google Scholar
• Gilbert F., Brazell C., Tricklebank M. D., Stahl S. M. Activation of the 5-HT1areceptor subtype increases rat plasma ACTH concentrations. European Journal of Pharmacology 1988; 14(7)431–439
   Google Scholar
• Golden R. N., Markey S. P., Risby E. D., Rudorfer M. V., Cowdry R. W., Potter W. Z. Antidepressants reduce whole blood norepinephrine turnover while enhancing 6-hydroxymelatonin outpatient. Archives of General Psychiatry 1988; 4(5)150–154
   Google Scholar
• Goodwin G. M., de Souza R. J., Green A. R. Presynaptic serotonin receptor-mediated response in mice attenuated by antidepressant drugs and electrocon-vulsive shock. Nature 1985; 31(7)531–533
   Google Scholar
• Grasby P. M., Begg E. J., Gartside S. E., Cowen P. J. Effect of Idazoxan on evening melatonin plasma concentrations in healthy volunteers. Biological Psychiatry 1989; 2(6)412–416
   Google Scholar
• Haase A. F., Greiner H. E., Seyfried C. A. Effects of Lofepramine in biochemical models of antidepressant acitivity. New Therapeutic Developments in Pharmacopsychiatry, H. Friedr. Vieweg Verlagsgesellschaft GbH, Braunschweig 1987; 19–28
   Google Scholar
• Harland D, Brown M. J. Effects of acute and chronic administration of Idazoxan on blood pressure and plasma catecholamine concentrations of rats. Journal of Pharmacology and Experimental Therapeutics 1988; 24(5)265–273
   Google Scholar
• Hedner T., Pettersson A., Persson B. Chronic 5-HT2receptor blockade by ritanserin does not reduce blood pressure in patients with essential hypertension. Acta Medico Scandinavica 1987; 22(2)307–310
   Google Scholar
• Hindmarch I. A pharmacological profile of Fluoxetine and other antidepressants on aspects of skilled performance and car handling ability. British Journal of Psychiatry 1988; 153(Suppl. 3)99–104
   Google Scholar
• Hindmarch I., Harrison C., Shillingford C. A. An investigation of the effects of Lofepramine, Nomifensine, Amitriptyline and Placebo on aspects of memory and psychomotor performance related to car driving. International Clinical Psychopharmacology 1986; 3: 157–165
   Web of Science ®Google Scholar
• Hulten B. A., Heath A. Clinical aspects of tricyclic antidepressant poisoning. Acta Medico. Scandinavica 1983; 21(3)275–278
   Google Scholar
• Hwang E., Magnussen I., VanWoert M. H. Effect of chronic Fluvoxamine administration on serotonin administration. Research Cmmunications in Chemical Pathology and Pharmacology 1980; 2(9)79–98
   Google Scholar
• Idzikowski C., Cowen P. J., Nutt D., Mills F. J. The effects of chronic ritanserin treatment on sleep and the neuroendocrine response to Tryptophan. Psychopharmacology 1987; 9(3)416–420
   Google Scholar
• Idzikowski C., Mills F. J., Glennard R. 5-hydroxytryptamine-2 antagonist increases human slow-wave sleep. Brain Research 1986; 37(8)164–168
   Google Scholar
• Jackisch R., Werle E., Hertting G. Identification of mechanisms involved in the modulation of release of noradrenaline in the hippocampus of the rabbit. in vitro, Neuropharmacology 1988; 23: 1363–1371
   Google Scholar
• Jann M. W. Buspirone: an update on a unique anxiolytic drug. Phamtacotherapy 1984; 8: 100–116
   Google Scholar
• Janssen P. A. The relevence of phamacological studies to sleep research in psychiatry. Pharmacopsychiatry 1988; 2(1)33–37
   Google Scholar
• Kerwin Robert W. Monoamine oxidase inhibitors: 30 years of progress. International Review of Psychiatry 1988; 2: 141–147
   Google Scholar
• Kennett G. A., Marcou M., Dourish C. T., Curzon G. Single administration of 5-HT1aagonists decreases 5-HT1apresynaptic but not post-synaptic receptor mediated responses: relationship to antidepressant-like actions. European Journal of Pharmacology 1987; 13(8)53–60
   Google Scholar
• Kruhlich L., Jurcovicova J., Le T. Prolactin release inhibiting properties of the alpha-2 adrenergic receptor antagonist Idazoxan: comparison with Yohimbine. Life Sciences 1989; 4(4)809–818
   Google Scholar
• Lancaster S. G., Gonzalez J. P. Lofepramine: a review of its pharmacodynamic and pharmacokinectic properties and therapeutic efficacy in depressive illness. Drugs 1990; 3(7)123–140
   Google Scholar
• Langer S. Z. Presynaptic regulation of the release of catecholamines. Pharmacology Reviews 1981; 3(2)337–362
   Google Scholar
• Lapierre Y. D., Rastogi R. B., Singhal R. L. Fluvoxamine influences serotonergic systems in the brain: neurochemical evidence. Neuropsychology 1983; 10: 213–216
   Google Scholar
• Lemberger L., Terman S., Rowe H., Billings R. The effect of Nisoxetine a potential antidepressant on biogenic amine uptake in man. British Journal of Clinical Pharmacology, 3: 215–220
   PubMed Web of Science ®Google Scholar
• Leonard B. E. A comparison of the pharmacological properties of the novel tricyclic antidepressant Lofepramine with its major metabolite Desipramine: a review. International Clinical Psychopharmacology 1976; 2: 281–287
   Google Scholar
• Leysen J. E., van Gompel P., Gommeren W., Woestenborghs R., Janssen P. A. J. Down-regulation of serotonin-S2 receptor sites in rat brain by chronic treatment with the serotonin-S2 antagonists Ritanserin and Setoperone. Psychopharmacology 1986; 8(8)434–444
   Google Scholar
• Maj J., Papp M., Skuza G., Bigajska K., Zazula M. The influence of repeated treatment with Imipramine. (+)- and (−)-Oxaprotiline on behavioural effects of Dopamine D1and D2agonists. Journal of Neural Transmission 1989; 7(7)29–38
   Google Scholar
• Martire M., Pistritto G., Preziosi P. Alpha-2 adrenoceptor blocking properties of Idazoxan stereoisomers: stereoselectivity for presynaptic alpha-2 adrenoceptors. Neuroscience Letters 1988; 8(6)328–333
   Google Scholar
• Meltzer H. Y., Flemming R., Robertson A. The effect of buspirone on prolactin and growth hormone secretion in man. Archives of General Psychiatry 1983; 40: 1099–2002
   PubMed Web of Science ®Google Scholar
• Mendelson W. B., Jacobs L. S., Reichman J. D., Othmer E., Cryer P. E., Trivedi B., Daughday W. H. Methysergide: suppression of sleep related prolactin secretion and enhancement of sleep related growth hormone secretion. Journal of Clinical Investigation 1975; 5(6)690–697
   Google Scholar
• Mogilnicka E., Zazula M., Wedzony K. Functional supersensitivity to the alpha-1 adrenoceptor agonist after repeated treatment with antidepressant drugs is not conditioned by beta down regulation. Neuropharmacology 1987; 2(6)1457–1461
   Google Scholar
• Muir N. C, Doxey J. C., Havler M. E., Clifford J. M. The use of ex vivo platelet aggregation to confirm the in vivo alpha-2 adrenoceptor antagonist effect of Idazoxan in man. Journal of Pharmacological Methods 1987; 1(8)95–102
   Google Scholar
• Montgomery I., Oswald I., Morgan K., Adam K. Trazodone enhances sleep in subjective quality but not in objective duration. British Journal of Clinical Pharmacology 1983; 1(6)139–144
   Google Scholar
• Oswald I., Adam K., Spiegel R. Human slow-wave sleep increased by a serotonin antagonist. Electro-encephalography and Clinical Neurophysiology 1982; 5(4)583–586
   Google Scholar
• Palazidou E., Papadopoulos A., Sitsen A., Stahl S., Checkley S. A. An alpha-2 antagonist, Org 3770, enhances nocturnal melatonin secretion in man. Psychopharmacology 1987; 97: 115–117
   Web of Science ®Google Scholar
• Peroutka S. J., Snyder S. H. Long-term antidepressant treatment decreases spiroperidol-labelled serotonin receptor binding. Science 1980; 210: 88–90
   PubMed Web of Science ®Google Scholar
• Pinder Roger M. The toxicity of antidepressants in overdose: incidence and mechanisms. International Review of Psychiatry 1989; 2: 213–227
   Google Scholar
• Plym Forshell G., Siwers B., Tuck J. R. Pharmacokinetics of Lofepramine in man: relationship to inhibition of noradrenaline uptake. European Journal of Clinical Pharmacology 1990; 9: 291–298
   Google Scholar
• Preziosi P., Martire M., Navarra P., Pistrttto G., Vacca M. Prolactin lowering ability of (+/−)-Idazoxan may be linked to a central noradrenergic — serotonergic interplay. Journal of Pharmacology and Experimental Therapeutics 1989; 24(9)256–263
   Google Scholar
• Price L. H., Charney D. S., Delgado P. L., Anderson G. M., Heninger G. R. Effects of Desipramine and Fluvoxamine treatment on the prolactin response to Tryptophan. Serotonergic function and the mechanism of antidepressant action. Archives of General Psychiatry 1989; 4(6)625–631
   Google Scholar
• Raiteri M., Maura G., Versace P. Functional evidence for two stereochemically different alpha-2 adrenoceptors regulating central norepinephrine and serotonin release. Journal of Pharmacology and Experimental Therapeutics 1983; 22(4)679–684
   Google Scholar
• Roos J. C. Cardiac effects of antidepressants. A comparison of the tricyclic antidepressants and Fluvoxamine. British Journal of Clinical Pharmacology 1983; 1(5)439–445
   Google Scholar
• Sack R. L., Lewy A. J. Desmethylimipramine treatment increases melatonin production in humans. Biological Psychiatry 1985; 2(1)406–409
   Google Scholar
• Scheinin H, Virtanen R. Effects of Yohimbine and Idazoxan on monoamine metabolites in rat cerebrospinal fluid. Life Sciences 1986; 3(9)1439–1446
   Google Scholar
• Schwabe U., Miyake M., Ohga Y., Daly J. W. 4-3-cyclopentyloxy-4-methoxy-2-pyrrolidone (ZK 62711): a potent inhibitor of adenosine cyclic 3′, 5′-monophosphate phosphodiesterases in homogenates and tissue slices from rat brain. Molecular Pharmacology 1976; 12: 900–910
   PubMed Web of Science ®Google Scholar
• Segawa T., Nomura Y., Tanaka A., Murakami H. Effect of Lofepramine and other antidepressants on the uptake of 5-hydroxytryptamine and noradrenaline into rat brain monoammergic neurons. Journal of Pharmacy and Pharmacology 1977; 2(9)139–142
   Google Scholar
• Shur E, Checkley S. A. Pupil studies in depressed patients; an investigation of the mechanisms of action of Desipramine. British Journal of Psychiatry 1982; 140: 181–184
   PubMed Web of Science ®Google Scholar
• Siwers B., Borg S., D'Elia G., Lundin G., Plym Forschell G., Raotma M., Roman G. Comparative clinical evaluation of Lofepramine and Imipramine: pharmacological aspects. Acta Psychiatrica Scandinavica 1977; 5(5)21–31
   Google Scholar
• Sjogren C. The pharmacological profile of Lofepramine, a new antidepressant drug. Neuropharmacology 1976; 19: 1213–1214
   Google Scholar
• Starke K. Presynaptic receptors and the control of noradrenaline release. Trends in Pharmacological Sciences 1980; 6: 268–271
   Google Scholar
• Stephenson J. D. Neuropharmacological studies of the serotonergic system. International Review of Psychiatry 1980; 2: 165–185
   Google Scholar
• Stern H., Konetschny J., Herrmann L., Sawe U., Belz G. G. Cardiovascular effects of single doses, of the antidepressants Amitriptyline and Lofepramine in healthy subjects. Pharmacopsychiatry 1990; 78: 272–277
   Google Scholar
• Struthers A. D., Burrin J. M., Brown M. J. Exercise induced increases in plasma catecholamines and growth hormone are augmented by selective alpha-2 adrenoceptor blockade in man. Neuroendocrinology 1986; 4(4)22–28
   Google Scholar
• Sulser F. Regulation and function of noradrenaline receptor systems in brain. Psychopharmacological aspects. Neuropharmacology 1984; 2(3)255–261
   Google Scholar
• Szabadi E., Gasner P., Bradshaw C. M. The peripheral anticholinergic activity of tricyclic antidepressants: comparison of Amitriptyline and Desipramine in human volunteers. British Journal of Psychiatry 1980; 13(7)433–439
   Google Scholar
• Thompson C, Checkley S. A. The effects of a allaproclate on the pupillary responses to tyramine, Phenylephrine and Pilocarpine in depressed patients. Psychopharmacology 1985; 85: 65–68
   PubMed Web of Science ®Google Scholar
• Thompson C., Mezey G., Corn T., Franey C., English J., Arendt J., Checkley S. A. The effect of Desipramine upon melatonin and cortisol secretion in depressed and normal subjects. British Journal of Psychiatry 1985; 14(7)389–393
   Google Scholar
• Tormey W. P., Buckley M. P., O'Kelly D. A., Conboy J., Finder R. M., Darragh M. D. Sleep-endocrine profile of the antidepressant Mianserin. Current Medical Research Opinion 1985; 6: 456–460
   Google Scholar
• U'Prichard D. C., Bechtel W. D., Rouot B. R., Snyder S. H. Multiple apparent a-noradrenergic receptor binding sites in rat brain: effect of 6-OH Dopamine. Molecular Pharmacology 1979; 1(6)47–60
   Google Scholar
• Waldmeier P. C., Baumann P. A., Wilhelm M., Bernasconi R., Maitre L. Selective inhibition of noradrenaline and serotonin uptake by C 49802 B- and CGP 6985A. European Journal of Pharmacology 1977; 4(6)387–391
   Google Scholar
• Washburn M, Moises H. C. Electrophysiological correlates of presynaptic alpha-2 receptor mediated inhibitors of norepinephrine release at locus coeruleus synapses in dentate gyrus. The Journal of Neuroscience 1980; 9: 2131–2140
   Google Scholar
• Wood K., Swade C., Abou-saleh M., Milln P., Coppen A. Drug plasma levels and platelet 5-HT uptake inhibition during long term treatment with Fluvoxamine or Lithium in patients with affective disorders. British Journal of Clinical Pharmacology 1983; 15(Suppl. 3)365–368
   Google Scholar